Madrid, Spain

Luis Miguel Ortega Mora

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 2.9

ph-index = 1


Company Filing History:


Years Active: 2009-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Luis Miguel Ortega Mora

Introduction

Luis Miguel Ortega Mora is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of biotechnology, particularly in vaccine development and diagnostics. His work has led to the filing of two patents that showcase his innovative approach to addressing infectious diseases.

Latest Patents

One of his latest patents focuses on a vaccine composition. This invention relates to new protein compositions and methods for producing these proteins. It also includes pharmaceutical compositions that comprise these proteins and methods for treating infections. Specifically, the invention details a protein composition that contains specified proteins in an amount significantly higher than those found in the whole tachyzoite, as determined by quantitative label-free liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Another significant patent involves the use of the gene NcSAG4 for diagnosing and preventing neosporosis. This invention encompasses the gene NcSAG4, its messenger RNA, and designed oligonucleotides based on its nucleotide sequence. It also includes the protein NcSAG4 encoded by this gene, along with its recombinant forms, expression vectors, and host cells. This invention aims to facilitate diagnosis and vaccination against neosporosis and serves as a specific marker for analyzing the pathogenesis of the disease.

Career Highlights

Luis Miguel Ortega Mora is affiliated with Universidad Complutense de Madrid, where he conducts his research and development activities. His academic background and research experience have positioned him as a key figure in the field of biotechnology.

Collaborations

He has collaborated with notable colleagues such as Javier Regidor Cerrillo and David Arranz Solís. Their joint efforts have contributed to advancing research in vaccine development and infectious disease diagnostics.

Conclusion

Luis Miguel Ortega Mora's innovative work in vaccine composition and diagnostics exemplifies the impact of research on public health. His contributions continue to pave the way for advancements in biotechnology and infectious disease management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…